| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1402039B1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 04/26/2006 | EP1359979B1 Anti cancer combination of substituted pyrroles and paclitaxel |
| 04/26/2006 | EP1313509B1 Treatment of tumors with acetylenes disubstituted with an heteroaromatic group and a substituted thiochromanyl group in combination with other anti-tumor agents |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1244454B1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/26/2006 | EP1218514B1 Designing immunogens |
| 04/26/2006 | EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 04/26/2006 | EP1187918B1 Tek antagonists |
| 04/26/2006 | EP1185666B1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 04/26/2006 | EP1105466B1 Process for purifying human papillomavirus virus-like particles |
| 04/26/2006 | EP1053313B1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences |
| 04/26/2006 | EP1002108B1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 04/26/2006 | EP0977562B8 Methods and compositions for delivery of taxanes |
| 04/26/2006 | CN1764723A Interleukin-18 mutants, their production and use |
| 04/26/2006 | CN1764720A Coding calicheamicin biosynthesis and micromonospora echinospora gene for same antagonism |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 04/26/2006 | CN1764660A Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764477A Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1764445A A method of treating breast cancer with androgen receptor antagonists |
| 04/26/2006 | CN1763195A Human Nanog gene and its encoded protein and application |
| 04/26/2006 | CN1763177A Novel bacillus and its separation method and application |
| 04/26/2006 | CN1763097A Polypeptide variants with altered effector function |
| 04/26/2006 | CN1763093A Survivin mutant containing HIV transduction structural area and its preparation method and uses |
| 04/26/2006 | CN1763089A C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 04/26/2006 | CN1763087A Towel gourd seed ribosome deactivated protein and its coding gene and uses |
| 04/26/2006 | CN1763083A Cyclopentapeptide extraction method and its uses in preparing anti-tumour medicine |
| 04/26/2006 | CN1763075A Solasodine hydrobromate and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763074A Solasodine hydrofluoric acid salt and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763073A Solasodine hydriodate and its preparation method and its uses in medicine |
| 04/26/2006 | CN1763071A Chinese Elder Herb general triterpene extraction process |
| 04/26/2006 | CN1763064A Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 04/26/2006 | CN1763047A Vinorelbine preparation method |
| 04/26/2006 | CN1762961A Quinone compounds and its preparation method and antineoplastic use |
| 04/26/2006 | CN1762496A Genetic drug for targeted treatment of liver cancer and its preparation process |
| 04/26/2006 | CN1762492A CD40 binding molecules and CTL peptides uses in pharmic composition for treating tumors |
| 04/26/2006 | CN1762491A Use of BCG as adjuvant of active protein activating cytotoxic T-lymphocyte |
| 04/26/2006 | CN1762490A Tumor antigen based on products of the tumor suppressor gent WT1 |
| 04/26/2006 | CN1762450A Application of magnolia vine fruit in preparation of anti-tumor medicine or multi-medicine tolerant reversal agent |
| 04/26/2006 | CN1762431A Giant knotweed pills formula and its preparation method |
| 04/26/2006 | CN1762416A Rehabilitation lyophilized powder injection and its preparation method |
| 04/26/2006 | CN1762406A Quality control method of ixeris sonchifolia injection |
| 04/26/2006 | CN1762380A Nano selenium product and its preparation method |
| 04/26/2006 | CN1762378A Indian bread polysaccharide formulation and its preparation method |
| 04/26/2006 | CN1762371A Application of stauntoniae sapoin in preparation of anti-tumor medicine |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1762364A Formula of blood brain barrier-passing quickly highly-efficient anti-cancer medicine and its preparation process |
| 04/26/2006 | CN1762363A Arteannuin pills formula and its preparation process |
| 04/26/2006 | CN1762346A Application of tripholide in preparation of anti-oophoroma medicine |
| 04/26/2006 | CN1762332A Temperature-controllable thermotherapeutic embolize micro-sphere and preparation method thereof |
| 04/26/2006 | CN1253551C Genetically modified tumor-targeted bacteria with reduced virulence |
| 04/26/2006 | CN1253469C Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof |
| 04/26/2006 | CN1253464C Ansi glycoside compound and its medicinal composition, preparation and use |
| 04/26/2006 | CN1253463C Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/26/2006 | CN1253458C Process for preparing substance GM-95 |
| 04/26/2006 | CN1253454C Beta-carboline and thio-analogues subsitituted by amino-acid radical/acyl, preparing method and application thereof |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253206C Method for obtaining antigenic aggregates and use thereof in formulations |
| 04/26/2006 | CN1253200C Sparganium qijia decoction for treating cancer |
| 04/26/2006 | CN1253164C Novel use of tuber fleeceflower stem extract |
| 04/26/2006 | CN1253152C Single particle nano-garlicin micro-capsule, and its preparation method |
| 04/25/2006 | USRE39078 Recombinant adenoviruses for gene therapy in cancers |
| 04/25/2006 | US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034111 17867, a novel human aminopeptidase |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034058 Anti-tumor pharmaceutical composition comprising N-vanillyl fatty acid amide |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034052 Anticancer agents; inflammatory bowel disorders; myelodysplastic syndrome |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034026 serine/threonine kinase inhibitors; 2,3-diphenylquinoxalines in which at least one of the phenyls is substituted with an amine group, particularly 2-[4-(2-aminoprop-2-yl)phenyl]-3-phenylquinoxaline; treating cancer |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034024 Synergistic mixture of 7-(2-amino-1-oxo-3-thiopropyl)-8-((cyclomethyl)-2-phenyl)-5,6,7,8-tetrahydroimidazolo(1,2-a)pyrazine and cisplatin |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034017 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033798 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033788 Saxatilin isolated via gel fitration of venom from vipers, then performing high performance liquid chromatography; for use as anti-platelet aggregation agents and antitumor agents |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033750 Recombinant P53 adenovirus methods and compositions |
| 04/25/2006 | US7033617 Use of Anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies |
| 04/25/2006 | US7033615 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 04/25/2006 | US7033606 Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis |
| 04/25/2006 | US7033594 Method of treatment using ligand-immunogen conjugates |
| 04/25/2006 | US7033591 use of a membrane fraction of gram-negative bacteria such as Klebsiella pnemoniae comprising proteoglycans in combination with anticancer treatment for immunostimulant and/or inducing an antitumor immune response in mammals including humans |
| 04/25/2006 | US7033583 A water soluble polymer conjugated drug containing mercaptan group; controlled pharmacokinetics and improved bioavailability, relative to unmodified bioactive materials |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | CA2237313C Aromatic carboxylic acid esters, the production of same and use of same as medicaments |